Specifically, they found that IL-2-activated circulating NK cells from RCC patients with mutated VHL exhibited higher degranulation levels and IFNγ production toward a mutated VHL RCC cell line than against a cell line with wild type VHL. This evidence concerns the gene IL2 and renal cell carcinoma.